Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Financials

Overview

IQ Biosciences is your trusted partner, powering preclinical discovery with in vitro assays, bioconjugation expertise, and dependable immune cells.

News

Blog 1 month ago
Choosing Isotype Controls for ADC Studies: Wild-Type or Fc-Silent?
In an antibody-drug conjugate (ADC) experiment, the choice of isotype control shapes how clearly target-specific activity can be separated from background. An isotype control accounts for effects that are not specific to the target, which makes choosing t
Read more
Report
Blog 6 months ago
The Hidden Variable in Your ADC Experiment: Why Isotype Controls Must Match the Whole Molecule
Antibody-drug conjugates (ADCs) have made remarkable progress in recent years, combining the specificity of targeted antibodies with the potent cell-killing ability of cytotoxic payloads. As these molecules grow more structurally complex, the design of ap
Read more
Report
Blog 5 years ago
The Suppressive Nature of Regulatory T Cells and Their Roles in Cancer and Diseases
Introduction to Regulatory T Cells The immune response is an exquisitely controlled event in which lymphocytes expand, secrete cytokines, and kill infected cells in response to foreign pathogens. At the peak of the immune response, extracellular organisms
Read more
Report
Blog 5 years ago
The ABCs of ADCs: An Introduction to Antibody-drug Conjugates
The terms "warhead" and "payload" typically invoke impressions of weapons and destruction. However, in a more constructive and positive light, these terms are now also commonly associated with antibody-drug conjugates (ADCs), a class of biologics used to
Read more
Report
Blog 7 years ago
ADCP: The Covert MoA for Therapeutic Antibodies You Need to Know About (Part 2)
In our previous blog, we discussed antibody-dependent cellular phagocytosis (ADCP), a mechanism of action for therapeutic antibodies that is becoming increasingly appreciated. In vitro and in vivo experiments show that ADCP, a process where phagocytic cel
Read more
Report
Blog 8 years ago
ADCP: The Covert MoA for Therapeutic Antibodies You Need to Know About (Part 1)
Therapeutic antibodies can work through various mechanisms of action. They can inhibit ligand-independent dimerization to prevent downstream survival and proliferation signaling pathways or induce apoptosis of target cells. In addition, therapeutic antibo
Read more
Report
Blog 8 years ago
Revisiting Complement, An Old Friend… (Part 3)
After summarizing how the complement system can have both anti-tumor and pro-tumor effects, we conclude our blog series on Reis et al. by discussing the clinical aspects of complement as a target and biomarker. As discussed in the previous blogs, the imba
Read more
Report
Blog 8 years ago
Revisiting Complement, An Old Friend… (Part 2)
Complement in promotion of tumorigenesis. The imbalance and dysfunction of complement activity and activation can lead to various mechanisms that promote tumorigenesis. These mechanisms can have affects on the immune cells to provide a more favorable tumo
Read more
Report
Blog 8 years ago
Revisiting Complement, An Old Friend… (Part 1)
The complement system of the innate immune system has been widely regarded as an early deterrent to infections and a means to clear pathogens by activating a group of proteins that leads to cell lysis, phagocytosis, and inflammation. In addition, the powe
Read more
Report
Show more news

Tech stack

Technologies named in job postings at iQ Biosciences over the last 12 months, by layer, with the share of postings for each.
Technologies in use
5
Postings analysed
1
Stack modernity
51/100
Developer tools
LIMS
FlowJo
GraphPad Prism
Practices & domains
Cell Culture
Flow Cytometry
Sign in to see how your skills match this stack Sign In

Salary insights

Compensation ranges based on this company's open jobs
Median
$83k
Typical range
$83k
Open positions
2
2 Jobs
Junior 100%
Level Jobs Median Typical range
Junior 2 $83k $83k
Highest paying role Project Coordinator I: Project Management & Client Support – (CA, AZ & MA) $83k
Normalized to USD per year

Growth

Hiring Momentum
63/100
Growing
Open positions
2
1 opened / 1 closed in 30 days
Median time-to-fill
22 days
faster than 53% of the market
ATS activity
Every ~4 hours
Today
Hiring Dynamics 0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Administrative
40% ▲
Science & Research
40% ▼
Operations
20% ▼
Activity Timeline
Added LIMS to stack Oct 2026
Added GraphPad Prism to stack Oct 2026
Added FlowJo to stack Oct 2026
Added Flow Cytometry to stack Oct 2026
Added Cell Culture to stack Oct 2026

Offices

Where the company hires and what each office is for
Earlier presence
Alameda, United States 3 open roles · last posting Sep 2026